Dapagliflozin aids glycemic control in type 2 diabetes

For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control and weight reductions, according to research published in the the Annals of Internal Medicine.


Read more

Posted in Type II Medical Research